Pharmacyclics Retaining R&D Operation in Sunnyvale, Expands to ±50,000 SF

Pharmacyclics, Inc. will retain its research and development operation in Sunnyvale, CA. The biopharmaceutical company—acquired by AbbVie last year—inked a new long-term direct deal with landlord Gray AREA Arques, a joint venture between Graymark Capital and Ascent Real Estate Advisors, for ±49,920 square feet of R&D space on the eastern side of the city. Pharmacyclics […]